0000899243-21-020330.txt : 20210521 0000899243-21-020330.hdr.sgml : 20210521 20210521140618 ACCESSION NUMBER: 0000899243-21-020330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210519 FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35986 FILM NUMBER: 21948201 BUSINESS ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECH TARGET N V CENTRAL INDEX KEY: 0001259870 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35986 FILM NUMBER: 21948202 MAIL ADDRESS: STREET 1: ARA HILL TOP BUILDING, UNIT A-5 STREET 2: PLETTERIJWEG OOST 1, CURACAO CITY: WILLEMSTAD STATE: P8 ZIP: 000000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Esperion Therapeutics, Inc. CENTRAL INDEX KEY: 0001434868 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3891 RANCHERO DRIVE, SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734-887-3903 MAIL ADDRESS: STREET 1: 3891 RANCHERO DRIVE, SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: HDL THERAPEUTICS INC DATE OF NAME CHANGE: 20080513 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-19 0 0001434868 Esperion Therapeutics, Inc. ESPR 0001259870 BIOTECH TARGET N V ARA HILL TOP BUILDING, UNIT A-5, PLETTERIJWEG OOST 1 CURACAO P8 00000 NETHERLANDS ANTILLES 0 0 1 0 0000924223 BB BIOTECH AG SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 CH-8200 SWITZERLAND 0 0 1 0 Common Stock 2021-05-19 4 P 0 200000 20.3698 A 4377964 D Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Esperion Therapeutics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V. /s/ Ivo Betschart 2021-05-21 /s/ Martin Gubler 2021-05-21